X-Linked Myotubular Myopathy: A Novel Mutation Expanding the Genotypic Spectrum of a Phenotypically Heterogeneous Myopathy

Abstract

X-linked myotubular myopathy (XLMTM), a centronuclear congenital myopathy secondary to pathogenic variants in the MTM1 gene encoding myotubularin, is typically recognized for its classic and severe phenotype which includes neonatal hypotonia, severe muscle weakness, long-term ventilator dependence, markedly delayed gross motor milestones with inability to independently ambulate, and a high neonatal and childhood mortality. However, milder congenital forms of the condition and other phenotypes are recognized. We describe a 6-year-old boy with a mild XLMTM phenotype with independent gait and no respiratory insufficiency even in the neonatal period. The child has a hemizygous novel splice site variant in the MTM1 gene (c.232–25A > T) whose pathogenicity was confirmed by cDNA studies (exon 5 skipping) and muscle biopsy findings. We also compared the phenotype of our patient with the few reported cases that presented a mild XLMTM phenotype and no respiratory distress at birth, and discussed the potential mechanisms underlying this phenotype such as the presence of residual expression of the normal myotubularin transcript.

Keywords

centronuclear myopathy - mild phenotype - MTM1 gene - myotubularin - X-linked myotubular myopathy

Publikationsverlauf

Eingereicht: 13. Dezember 2020

Angenommen: 09. März 2021

Artikel online veröffentlicht:
01. Juni 2021

• References

• 1 Laporte J, Hu LJ, Kretz C. et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet 1996; 13 (02) 175-182
• 2 Dowling JJ, Lawlor MW, Das S. X–Linked Myotubular Myopathy. GeneReviews®. 2002 February 25 [Updated 2018 August 23]. Accessed September 28, 2020 at: https://www.ncbi.nlm.nih.gov/books/NBK1432/#:~:text=X%2Dlinked%20myotubular%20myopathy%20(X,ranges%20from%20severe%20to%20mild
• 3 Herman GE, Finegold M, Zhao W, de Gouyon B, Metzenberg A. Medical complications in long-term survivors with X-linked myotubular myopathy. J Pediatr 1999; 134 (02) 206-214
• 4 Barth PG, Dubowitz V. X-linked myotubular myopathy--a long-term follow-up study. Eur J Paediatr Neurol 1998; 2 (01) 49-56
• 5 Buj-Bello A, Biancalana V, Moutou C, Laporte J, Mandel JL. Identification of novel mutations in the MTM1 gene causing severe and mild forms of X-linked myotubular myopathy. Hum Mutat 1999; 14 (04) 320-325
• 6 Biancalana V, Caron O, Gallati S. et al. Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. Hum Genet 2003; 112 (02) 135-142
• 7 Yu S, Manson J, White S. et al. X-linked myotubular myopathy in a family with three adult survivors. Clin Genet 2003; 64 (02) 148-152
• 8 Pierson CR, Tomczak K, Agrawal P, Moghadaszadeh B, Beggs AH. X-linked myotubular and centronuclear myopathies. J Neuropathol Exp Neurol 2005; 64 (07) 555-564
• 9 Pierson CR, Agrawal PB, Blasko J, Beggs AH. Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy. Neuromuscul Disord 2007; 17 (07) 562-568
• 10 de Goede CG, Kelsey A, Kingston H, Tomlin PI, Hughes MI. Muscle biopsy without centrally located nuclei in a male child with mild X-linked myotubular myopathy. Dev Med Child Neurol 2005; 47 (12) 835-837
• 11 Shieh PB, Kuntz N, Smith B. et al. ASPIRO gene therapy trial in X–linked myotubular myopathy (XLMTM): update on preliminary safety and efficacy findings up to 72 weeks post-treatment (1053). Neurology 2020; 94 (15) 1053
• 12 Tajsharghi H, Leren TP, Abdul-Hussein S. et al. Unexpected myopathy associated with a mutation in MYBPC3 and misplacement of the cardiac myosin binding protein C. J Med Genet 2010; 47 (08) 575-577
• 13 Cocanougher BT, Flynn L, Yun P. et al. Adult MTM1-related myopathy carriers: classification based on deep phenotyping. Neurology 2019; 93 (16) e1535-e1542
• 14 Hoffjan S, Thiels C, Vorgerd M, Neuen-Jacob E, Epplen JT, Kress W. Extreme phenotypic variability in a German family with X-linked myotubular myopathy associated with E404K mutation in MTM1. Neuromuscul Disord 2006; 16 (11) 749-753
• 15 Oliveira J, Oliveira ME, Kress W. et al. Expanding the MTM1 mutational spectrum: novel variants including the first multi-exonic duplication and development of a locus-specific database. Eur J Hum Genet 2013; 21 (05) 540-549
• 16 Al-Hashim A, Gonorazky HD, Amburgey K, Das S, Dowling JJ. A novel intronic mutation in MTM1 detected by RNA analysis in a case of X-linked myotubular myopathy. Neurol Genet 2017; 3 (05) e182
• 17 McEntagart M, Parsons G, Buj-Bello A. et al. Genotype-phenotype correlations in X-linked myotubular myopathy. Neuromuscul Disord 2002; 12 (10) 939-946
• 18 Tosch V, Vasli N, Kretz C. et al. Novel molecular diagnostic approaches for X-linked centronuclear (myotubular) myopathy reveal intronic mutations. Neuromuscul Disord 2010; 20 (06) 375-381
• 19 Laporte J, Kress W, Mandel JL. Diagnosis of X-linked myotubular myopathy by detection of myotubularin. Ann Neurol 2001; 50 (01) 42-46